Quellis Biosciences

Quellis Biosciences is committed to improving the lives of patients with severe rare diseases by developing a new generation of antibody therapies that provide value by improving patient outcomes. Quellis was founded to offer the best treatment options to patients with severe rare diseases whose current therapeutic options are insufficient.